Ayvens (FRA:3AL)
Germany flag Germany · Delayed Price · Currency is EUR
9.57
+0.10 (1.11%)
Last updated: Jul 31, 2025

Intra-Cellular Therapies Revenue

Ayvens had revenue of 6.21B EUR in the quarter ending June 30, 2025, a decrease of -2.48%. This brings the company's revenue in the last twelve months to 25.19B, up 4.67% year-over-year. In the year 2024, Ayvens had annual revenue of 25.27B with 35.16% growth.

Revenue (ttm)
25.19B
Revenue Growth
+4.67%
P/S Ratio
0.30
Revenue / Employee
1.83M
Employees
14,381
Market Cap
7.55B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202425.27B6.57B35.16%
Dec 31, 202318.70B7.28B63.82%
Dec 31, 202211.41B942.00M9.00%
Dec 31, 202110.47B578.20M5.84%
Dec 31, 20209.89B182.70M1.88%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition